SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14655041
Source:
http://linkedlifedata.com/resource/pubmed/id/14655041
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0011777
,
umls-concept:C0034656
,
umls-concept:C0042963
,
umls-concept:C0526950
,
umls-concept:C2587213
pubmed:issue
1
pubmed:dateCreated
2004-1-9
pubmed:abstractText
To establish whether the combination of a corticosteroid (dexamethasone) and the newer serotonin-3 (5-HT(3)) receptor antagonist ramosetron is superior to ramosetron alone in controlling cisplatin-induced emesis.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9302957
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiemetics
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone
,
http://linkedlifedata.com/resource/pubmed/chemical/ramosetron
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0941-4355
pubmed:author
pubmed-author:ChanValorieV
,
pubmed-author:VillalonAntonioA
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
58-63
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14655041-Adult
,
pubmed-meshheading:14655041-Aged
,
pubmed-meshheading:14655041-Antiemetics
,
pubmed-meshheading:14655041-Antineoplastic Agents
,
pubmed-meshheading:14655041-Benzimidazoles
,
pubmed-meshheading:14655041-Cisplatin
,
pubmed-meshheading:14655041-Dexamethasone
,
pubmed-meshheading:14655041-Drug Therapy, Combination
,
pubmed-meshheading:14655041-Female
,
pubmed-meshheading:14655041-Humans
,
pubmed-meshheading:14655041-Male
,
pubmed-meshheading:14655041-Middle Aged
,
pubmed-meshheading:14655041-Neoplasms
,
pubmed-meshheading:14655041-Time Factors
,
pubmed-meshheading:14655041-Treatment Outcome
,
pubmed-meshheading:14655041-Vomiting
pubmed:year
2004
pubmed:articleTitle
Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis.
pubmed:affiliation
Manila Doctors Hospital, T.M. Kalaw Street, Manila, Philippines. ahvillalon@yahoo.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study